- Filed
- May 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 12, 2026 | 190.01M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 225.64M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 191M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$237.18K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$161.91K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$51.39M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$113.4M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$45.86M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | −$44.55M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $51.82M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $114.82M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $51.82M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $114.89M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $430.42K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.48M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $430.42K |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.48M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.01 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.27 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.01 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $34.49K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $6.51K |
| Net Income | Q1 2026 · Mar 31, 2026 | $62.01M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.4M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$487.67K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$246.8K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | −$259.47K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $44.27K |
| Revenue | Q1 2026 · Mar 31, 2026 | $403.52K |
| Revenue | Q1 2026 · Mar 31, 2025 | $173.04K |